Analytical role in clinical toxicology: Impact on the diagnosis and treatment of poisoned patients;Bedeutung der Analytik in der Klinischen Toxikologie: Auswirkungen auf die Diagnostik und Behandlung Vergifteter Patienten

LaboratoriumsMedizin

Volumn 33, Issue 2, 2009, Pages 71-87

  Hallbach, Jürgen ^a,e   Degel, Fritz ^b   Desel, Herbert ^c   Felgenhauer, Norbert ^d  

^a Institute of Clinical Chemistry and Immunology   (Germany)

^b KLINIKUM NÜRNBERG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Munich Municipal Hospital   (Germany)

Author keywords

Analytical toxicology; Chromatography; Emergency medicine; Toxicological centres

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; COCAINE; DEXTROPROPOXYPHENE; DIGOXIN; ETHYLENE GLYCOL; LITHIUM; METHANOL; OPIATE; PARACETAMOL; PARAQUAT; PHENCYCLIDINE; PHENOBARBITAL; SALICYLIC ACID; THEOPHYLLINE; TRANSFERRIN;

CLINICAL CHEMISTRY; DRUG OVERDOSE; HEMATOLOGICAL PARAMETERS; HUMAN; INTOXICATION; REVIEW;

EID: 65349120027     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2009.021     Document Type: Review

References (48)

1. Flanagan RJ. Developing an analytical toxicology service: principles and guidance. Toxicol Rev 2004;23:251-63.
2. Proudfoot AT. Clinical assessment of the poisoned patient - general principles. 12th Course on advances in Clinical Toxicology 1996, Birmingham, United Kingdom.
3. Arnold W. Cooperation between clinical intensive care units with forensic and toxicologic laboratories of institutes for forensic medicine in the treatment of acute poisoning. Anaesthesist 1969;18:353-8.
4. Free AH, Free HM. Urinalysis, critical discipline of clinical science. CRC Crit Rev Clin Lab Sci 1972;3:481-531.
5. Wallace JE, Blum K, Singh JM. Determination of drugs in biological specimens - a review. Clin Toxicol 1974;7: 477-95.
6. Hepler BR, Sutheimer CA, Sunshine I. The role of the toxicology laboratory in emergency medicine. Clin Toxicol 1982;19:353-65.
7. Hepler B, Sutheimer C, Sunshine I. Role of the toxicology laboratory in suspected ingestions. Pediatr Clin North Am 1986;33:245-60.
8. Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Meyer TP, et al. National academy of clincal biochemistry laboratory medicine practice guidelines: Recommendations for the use of laboratory test to support poisoned patients who present to the emergency department. Clin Chem 2003;49:357-79.
9. Kü lpmann WR, editor. Klinisch-toxikologische Analytik - Verfahren, Befund, Interpretation. Weinheim (Germany): Whiley-VCH, 2002.
10. Kü lpmann WR, editor. Clinical toxicological analysis. Procedures, results, interpretation. Weinheim (Germany): Whiley- VCH, 2009.
11. Fukumoto M. Analytical role in clinical toxicology - impact on the diagnosis and treatment of a poisoned patient. Rinsho Byori 2008;56:330-4.
12. Baud FJ, Megarbane B, Deye N, Leprince P. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care 2007;11:207.
13. Flanagan RJ, Widdop B, Ramsey JD, Loveland M. Analytical toxicology. Hum Toxicol 1988;7:489-502.
14. Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clin Chim Acta 2006;366:101-11.
15. Schö nberg L, Grobosch T, Lampe D, Kloft C. Toxicological screening in urine: comparison of two automated HPLC screening systems, toxicological identification system (TOX.I.S) versus REMEDI-HS. J Anal Toxicol 2007;31:321-7.
16. Maurer HH. Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. J Chromatogr B Biomed Sci Appl 1999;733:3-25.
17. Maurer HH. Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. Comb Chem High Throughput Screen 2000;3:467-80.
18. Hallbach J. A fast and sensitive method for GC-MS screening in acute poisoning. Clin Tox 2003;41:558.
19. Maurer HH. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med 2004;42:1310-24.
20. Maurer HH. Hyphenated mass spectrometric techniques - indispensable tools in clinical and forensic toxiclogy and in doping control. Mass spectrum 2006;41:1399-413.
21. Maurer HH. Role of gas chromatography - mass spectrometry with negative ion chemical ionization in clinical and forensic toxicology, doping control, and biomonitoring. Ther Drug Monit 2002;24:247-54.
22. Marquet P, Lachatre G. Liquid chromatography - mass spectrometry: potential in forensic and clinical toxicology. Chromatogr B Biomed Sci Appl 1999;733:93-118.
23. Maurer HH. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 2007;388:1315-25.
24. Valli A, Polettini A, Papa P, Montagna M. Comprehensive drug screening by integrated use of gas chromatography/ mass spectrometry and Remedi HS.Ther Drug Monit 2001; 23:287-94.
25. Hallbach J, Guder WG. Fast diagnosis of acute intoxications by a combined laboratory strategy of HPLC and GC-MS after ultrasonic derivatisation. Tth Alps-Adria Congress Regensburg 2002:108.
26. Mü ller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrometr 2005;19:1332-8.
27. Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanperä I. Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry. Ther Drug Monit 2008;30:717-24.
28. Bakdash A, Meyer-von A, Pragst F, Hallbach J. Detection of metabolites of selected psychoactive drugs in systematic toxicological analysis by LC-ESI-MS-TOF. Submitted 2009.
29. Megarbane B, Baud FJ. Interest of toxicological analysis for poisonings. Rev Prat 2008;58:838-43.
30. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta 2002; 315:125-35.
31. Heyerdahl F, Hovda KE, Bjornaas MA, Brors O, Ekeberg O, Jacobsen D. Clinical assessment compared to laboratory screening in acutely poisoned patients. Hum Exp Toxicol 2008;27:73-9.
32. Helland A, Espnes KA, Reimers A, Aamo T, Zahlsen K, Rygnestad T, et al. Toxicological screening of medicines and drugs of abuse in emergency cases. Tidsskr Nor Laegeforen 2008;128:42-5.
33. Epstein FB, Hassan M. Therapeutic drug levels and toxicology screen. Emerg Med Clin North Am 1986;4:367-76.
34. Tournier M, Molimard M, Titier K, Cougnard A, Begaud B, Gbikpi-Benissan G, et al. Accuracy of information on substance use recorded in medical charts of patients with intentional drug overdose. Psychiatr Res 2007;152:73-9.
35. Sugarman JM, Rodgers GC, Paul RI. Utility of toxicology screening in a pediatric emergency department. Pediatr Emerg Care 1997;13:194-7.
36. Belson MG, Simon HK. Utility of comprehensive toxicological screens in children. Am J Emerg Med 1999;17:221-4.
37. Hä ssler F, Zamorski H, Weirich S. The problem of differentiating between sudden infant death syndrome, fatal Munchhausen's syndrome by proxy, and infanticide. Z Kinder Jugendpsychiatr Psychother 2007;35:237-44.
38. Casavant MJ. Urine drug screening in adolescents. Pediatr Clin North Am 2002;49:317-27.
39. Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol 2004;42:1-26.
40. Hallbach J. The quot;diagnostic pathways in toxicologyquot; project - a multidisciplinary approach. Clin Toxicol 2009.
41. Gibitz HJ. Emergency tests in the central laboratory of a hospital. Wien Med Wochenschr 1981;131:345-51.
42. Hallbach J, Guder WG. Mechanized toxicological serum tests in screening hospitalized patients. Eur J Clin Chem Clin Biochem 1991;29:537-47.
43. Kennedy M, Kiloh N. Drugs and brain death. Drug Saf 1996;14:171-80.
44. Hallbach J, von Meyer L, Maurer HH. Empfehlungen des Arbeitskreises Klinische Toxikologie der Gesellschaft fü r Toxikologische und Forensische Chemie (GTFCh) fü r die toxikologische Analytik im Rahmen der Hirntodfeststellung. TqK 2002;124-127.
45. Heinzow BG, McLean A. Critical evaluation of current concepts in exposure assessment. Clin Chem 1994;40: 1368-75.
46. Gil F, Pia A. Biomarkers as biological indicators of xenobiotic exposure. J Apl Toxicol 2001;21:245-55.
47. Vale JA. What is the optimum management of late presentation paracetamol poisoning. 12th Course on advances in clinical toxicology. Birmingham 1996.
48. Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol 2005; 42:202-9.